PL4117790T3 - Lipopolisacharydy (lps) pozbawione toksyczności, naturalnie nietoksyczne lps i ich zastosowania - Google Patents

Lipopolisacharydy (lps) pozbawione toksyczności, naturalnie nietoksyczne lps i ich zastosowania

Info

Publication number
PL4117790T3
PL4117790T3 PL21710521.2T PL21710521T PL4117790T3 PL 4117790 T3 PL4117790 T3 PL 4117790T3 PL 21710521 T PL21710521 T PL 21710521T PL 4117790 T3 PL4117790 T3 PL 4117790T3
Authority
PL
Poland
Prior art keywords
lps
toxic
naturally non
detoxified lipopolysaccharides
detoxified
Prior art date
Application number
PL21710521.2T
Other languages
English (en)
Inventor
Martine Caroff
Alexey NOVIKOV
Original Assignee
Hephaistos-Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hephaistos-Pharma filed Critical Hephaistos-Pharma
Publication of PL4117790T3 publication Critical patent/PL4117790T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/804—Blood cells [leukemia, lymphoma]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
PL21710521.2T 2020-03-13 2021-03-12 Lipopolisacharydy (lps) pozbawione toksyczności, naturalnie nietoksyczne lps i ich zastosowania PL4117790T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20305264 2020-03-13
PCT/EP2021/056428 WO2021180972A1 (en) 2020-03-13 2021-03-12 Detoxified lipopolysaccharides (lps), naturally non-toxic lps, and uses thereof

Publications (1)

Publication Number Publication Date
PL4117790T3 true PL4117790T3 (pl) 2025-05-05

Family

ID=71120135

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21710521.2T PL4117790T3 (pl) 2020-03-13 2021-03-12 Lipopolisacharydy (lps) pozbawione toksyczności, naturalnie nietoksyczne lps i ich zastosowania

Country Status (11)

Country Link
US (1) US20230173064A1 (pl)
EP (2) EP4512482A3 (pl)
JP (2) JP2023541497A (pl)
KR (1) KR102906404B1 (pl)
CN (1) CN116249720B (pl)
AU (1) AU2021235152B2 (pl)
CA (1) CA3171408A1 (pl)
DK (1) DK4117790T3 (pl)
ES (1) ES3007532T3 (pl)
PL (1) PL4117790T3 (pl)
WO (1) WO2021180972A1 (pl)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
PT1127137E (pt) * 1998-11-03 2007-12-28 Staat Nl Verteg Door Min Welzi Lps com toxicidade reduzida a partir de bactérias gramnegativas modificadas geneticamente
DE10013539B4 (de) * 2000-03-20 2006-07-13 Pharma-Zentrale Gmbh Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen
WO2001090129A2 (en) * 2000-05-19 2001-11-29 Corixa Corporation Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
FR2848223B1 (fr) 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
CA2475736A1 (en) * 2004-07-23 2006-01-23 Cyrille Grandjean Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
EP2326671A4 (en) * 2008-09-05 2012-10-03 Ca Nat Research Council LIPOPOLYOSIDIC VACCINES
US10358667B2 (en) * 2013-03-07 2019-07-23 University Of Maryland, Baltimore Immunotherapeutic potential of modified lipooligosaccharides/lipid A
US11052142B2 (en) * 2013-06-04 2021-07-06 Petr G. Aparin Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
CA2955445A1 (en) * 2014-07-17 2016-01-21 Brian J. Czerniecki Manufacturing of multi-dose injection ready dendritic cell vaccines and combination therapy for blocking her2 and her3
CN107531736B (zh) * 2015-01-06 2022-04-15 免疫疫苗科技公司 脂质a模拟物、其制备方法和用途
EP3386536A4 (en) 2015-12-07 2019-07-31 Opi Vi- IP Holdco LLC COMPOSITION OF ANTIBODY CONSTRUCT AGONIST CONJUGATES AND METHOD FOR USE THEREOF
US11292808B2 (en) * 2016-01-28 2022-04-05 Intravacc B.V. Modified hexa-acylated neisserial LPS
KR102888356B1 (ko) * 2016-01-28 2025-11-19 인트라백 비.브이. 변형된 테트라-아실화된 나이세리아 lps
AU2017351900B2 (en) * 2016-10-31 2020-11-26 Eyegene Inc. Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same
WO2018080252A1 (ko) * 2016-10-31 2018-05-03 아이진 주식회사 면역반응 조절물질 및 이를 포함하는 백신 조성물
BR112019018905A2 (pt) * 2017-03-13 2020-05-19 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport vacinas contra bordetella compreendendo lps com reatogenicidade reduzida
US11419901B2 (en) * 2018-01-23 2022-08-23 Trustees Of Tufts College Porphyromonas gingivalis immune modulators and uses thereof

Also Published As

Publication number Publication date
CA3171408A1 (en) 2021-09-16
KR20230074410A (ko) 2023-05-30
EP4117790B1 (en) 2024-11-27
DK4117790T3 (da) 2025-01-27
AU2021235152A1 (en) 2022-11-10
KR102906404B1 (ko) 2025-12-31
JP2026048819A (ja) 2026-03-17
AU2021235152B2 (en) 2026-02-05
WO2021180972A1 (en) 2021-09-16
JP2023541497A (ja) 2023-10-03
US20230173064A1 (en) 2023-06-08
EP4117790A1 (en) 2023-01-18
ES3007532T3 (en) 2025-03-20
EP4512482A3 (en) 2025-04-16
CN116249720B (zh) 2024-12-03
CN116249720A (zh) 2023-06-09
EP4512482A2 (en) 2025-02-26

Similar Documents

Publication Publication Date Title
ZA201100347B (en) Clean room suit and the like
IL194118A0 (en) Flexible, compressed intravaginal rings, and methods of making the same
EP1571910A4 (en) CYTOTHERAPEUTIC AGENTS, CYTOTHERAPEUTIC UNITS AND METHODS OF TREATMENT IN WHICH THEY INTERVENE
GB0521333D0 (en) Method and apparatus for encrypting, obfuscating and reconstructing datasets or objects
SG11202102292XA (en) Ethernet header compression method, ethernet header decompression method, and device
GB202400788D0 (en) Neorhizobium SP, and use thereof
EP4134864A4 (en) METHOD FOR DETERMINING A STANDARD HUMAN PHENOTYPICAL TERM AND ASSOCIATED APPARATUS
WO2004082366A3 (en) Methods to confer enhanced floral properties to plants
CA119472S (en) Air freshener device
DK1679972T3 (da) Aromatisering af et mælkeprodukt med mindst én bakterie, som producerer et bacteriocin og tilhörer slægten Pediococcus
DK4117790T3 (da) Detoksificerede lipopolysaccharider (lps), naturligt ikke-toksisk lps og anvendelser deraf
GB2626637B (en) Compositions, methods and uses
GB202503378D0 (en) Cooking devices, methods, and components thereof
WO2003090598A3 (en) Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
GB202317463D0 (en) Compositions, methods and uses
GB202305630D0 (en) Compositions, methods and uses
GB202109510D0 (en) Copolymers and related methods, uses and components
GB202313513D0 (en) Compositions and methods for improving relaxation, sleep, cognition, and/or physical performance
PL2066340T3 (pl) Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej
EP4382956A4 (en) LIGHT-EMITTING DEVICE, DISTANCE IMAGING DEVICE AND MONITORING DEVICE
IL175052A0 (en) Anti-traction, mobility denial methods and products
PL3882555T3 (pl) Jednostka rekuperacji, urządzenie do sterylizacji zawierające jednostkę rekuperacji i powiązany sposób
EP3978099A4 (en) GAS TREATMENT METHOD AND GAS TREATMENT DEVICE
GB202415328D0 (en) Compositions, methods and uses
GB202212934D0 (en) Illumination device, method and systems